openPR Logo
Press release

Investigation announced for Investors who lost money with Legend Biotech Corporation (NASDAQ: LEGN) concerning possible Wrongdoing

An investigation on behalf of investors in Legend Biotech Corporation (NASDAQ: LEGN) shares over potential wrongdoing.

An investigation on behalf of investors in Legend Biotech Corporation (NASDAQ: LEGN) shares over potential wrongdoing.

An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Legend Biotech Corporation.

Investors who purchased shares of Legend Biotech Corporation (NASDAQ: LEGN) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain Legend Biotech Corporation directors breached their fiduciary duties and caused damage to the company and its shareholders.

Somerset, NJ based Legend Biotech Corporation, a clinical-stage biopharmaceutical company, engages in the discovery and development of novel cell therapies for oncology and other indications. Legend Biotech Corporation reported that its annual Total Revenue rose from 489.79 million in 2021 to $117 million in 2022, and that its Net Loss increased from $386.2 million in 2021 to $446.34 million in 2022.

On November 28, 2023, the U.S. Food and Drug Administration ("FDA") announced that it "is investigating the identified risk of T cell malignancy with serious outcomes, including hospitalization and death, and is evaluating the need for regulatory action" after "receiving reports of T-cell malignancies, including chimeric antigen receptor CAR-positive lymphoma, in patients who received treatment with BCMA- or CD19-directed autologous CAR T cell immunotherapies." The FDA's press release listed Legend's Carvykti (ciltacabtagene autoleucel) as among the approved products in the class of products at issue.

Shares of Legend Biotech Corporation (NASDAQ: LEGN) declined from $77.32 per share in July 2023, to as low as $57.24 per share on November 28, 2023.

Those who purchased shares of Legend Biotech Corporation (NASDAQ: LEGN) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Investors who lost money with Legend Biotech Corporation (NASDAQ: LEGN) concerning possible Wrongdoing here

News-ID: 3498419 • Views:

More Releases from Shareholders Foundation, Inc.

Novo Nordisk A/S (NYSE: NVO) Long Term Investor Alert: Investigation of potential Wrongdoing
Novo Nordisk A/S (NYSE: NVO) Long Term Investor Alert: Investigation of potentia …
An investigation on behalf of current long-term investors in shares of Novo Nordisk A/S (NYSE: NVO) concerning potential breaches of fiduciary duties by certain directors and officers was announced. Investors who are current long term investors in Novo Nordisk A/S (NYSE: NVO) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for long term investors in
Lawsuit filed for Investors who lost money with shares of Fortinet, Inc. (NASDAQ: FTNT)
Lawsuit filed for Investors who lost money with shares of Fortinet, Inc. (NASDAQ …
An investor, who purchased shares of Fortinet, Inc. (NASDAQ: FTNT), filed a lawsuit over alleged violations of Federal Securities Laws by Fortinet, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Fortinet, Inc. (NASDAQ: FTNT) have certain options and for certain investors are short and strict deadlines running. Deadline: November 21, 2025. NASDAQ: FTNT investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)
CTO Realty Growth, Inc. (NYSE: CTO) Investor Alert: Deadline in Lawsuit on October 07, 2025
CTO Realty Growth, Inc. (NYSE: CTO) Investor Alert: Deadline in Lawsuit on Octob …
A deadline is coming up on October 07, 2025in the lawsuit filed for certain investors of CTO Realty Growth, Inc. (NYSE: CTO) over alleged securities laws violations by CTO Realty Growth, Inc. Investors who purchased shares of CTO Realty Growth, Inc. (NYSE: CTO) have certain options and there are strict and short deadlines running. Deadline: October 07, 2025. CTO Realty Growth, Inc. (NYSE: CTO) stockholders should contact the Shareholders Foundation at
Alert: Lawsuit filed for Investors who lost money with shares of Jasper Therapeutics, Inc. (NASDAQ: JSPR)
Alert: Lawsuit filed for Investors who lost money with shares of Jasper Therapeu …
An investor, who purchased shares of Jasper Therapeutics, Inc. (NASDAQ: JSPR), filed a lawsuit over alleged violations of Federal Securities Laws by Jasper Therapeutics, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Jasper Therapeutics, Inc. (NASDAQ: JSPR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 18, 2025. NASDAQ: JSPR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com

All 5 Releases


More Releases for Legend

Arizona's Hip-Hop Renaissance: Legend and DJ CEO Unite for 'Eternal Legend'
Image: https://www.abnewswire.com/upload/2025/04/f93064da3f1df2746274def89c3ec12f.jpg Arizona is about to shake the hip-hop world. Rising star and lyrical powerhouse Legend has joined forces with renowned tastemaker DJ CEO for a game-changing collaborative album titled Eternal Legend - and it's already being hailed as the most anticipated project to ever come out of the Grand Canyon State. Blending street wisdom with raw storytelling and sharp production, Eternal Legend is more than just an album - it's a
JazzJoyandRoy.com Applauds Local Living Legend Bill Morris
When listeners Willie and Pamela Bell wrote in to Jazz Joy and Roy Global Radio recently to ask how Bible Ball Inc got started, JazzJoyandRoy.com founder Roy O'Dell Gray turned on the mic and responded, "The idea hit me like a proverbial ton of bricks or a Mac truck, after I unwittingly played a pickup set of tennis with the recognized number one pickleball player who would later become the
Shiva Sethuraman's The Legend of Misty Mountains
Shiva Sethuraman is pleased to announce the promotion of his young adult fantasy novel, The Legend of Misty Mountains. A clash between two conflicting beliefs. Of good vs evil. Of courage, vision, compassion and hope on one side and hatred, deceit, hostility and treachery on the other… Misty Mountains is a magical abode nestled among the clouds and inhabited by The Strange People. It had been established by the Lightning Strikers
Zidane - The Story of a Legend
Zidane was born on 23rd of June 1972 in Marseille. He started his youth career with local team Saint-Henri. Only a year and a half later he joined SO Septemes-les-Vallons where he stayed until age 14, as he was chosen to attend a 3-day training camp at CREPS (a centre for sports) run by the French Football Federation. Whilst attending, Zidane was spotted by the AS Cannes scout and was
An office legend turns 60
New: Stenorette in trendy black Bayreuth, 10th March 2014 – In 2014, Grundig Business Systems GmbH (GBS), one of the global leaders in supplying professional dictation systems, is celebrating the 60th anniversary of the Stenorette. The analogue dictation device was first launched in 1954 and has been sold – through many generations – almost 4.5 million times. “Because of its green color, the first Stenorette got the nickname 'tree frog'. It
Hidden Beach Signs Jazz Legend Ramsey Lewis
September 8, 2011 (Los Angeles, CA) Los Angeles based boutique label Hidden Beach Recordings announced earlier this month the signing of legendary jazz pianist Ramsey Lewis. The three time Grammy® winner who rose to prominence in the early 1970’s will release his 80th collection on September 20, 2011 entitled Ramsey, Taking Another Look., On the ten song CD Lewis and his Electric Band breathe new life into many of